Details:

Alternative Title:
Clin Pharmacol Ther
Publisher's site:
http://dx.doi.org/10.1038/clpt.2013.226
Personal Author:
Dotson, WD ; Douglas, MP ; Kolor, K ; Stewart, AC ; Bowen, MS ; ... More +
Dotson, WD ; Douglas, MP ; Kolor, K ; Stewart, AC ; Bowen, MS ; Gwinn, M ; Wulf, A ; Anders, HM ; Chang, CQ ; Clyne, M ; Lam, TK ; Schully, SD ; Marrone, M ; Feero, WG ; Khoury, MJ Less -
Description:
As evidence accumulates on the use of genomic tests and other health-related applications of genomic technologies, decision makers may increasingly seek support in identifying which applications have sufficiently robust evidence to suggest they might be considered for action. As an interim working process to provide such support, we developed a horizon-scanning method that assigns genomic applications to tiers defined by availability of synthesized evidence. We illustrate an application of the method to pharmacogenomics tests.
Subject:
[+]
Article
Decision Making
Genetic Testing
Genomics
Human Genome Project
Humans
Pharmacogenetics

Source:
Clin Pharmacol Ther. 95(4):394-402.
Pubmed ID:
24398597
Pubmed Central ID:
PMC4689130
Document Type:
Journal Article
Funding:
CC999999/Intramural CDC HHS/United States
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:b073bc6f25d86e7422969df63204d7bafe8f2e3b33663b13b26878f4199388ef
File Type:

Supporting Files

• 	nihms742922.nxml	bin
  	nihms742922f1.gif	gif
  	nihms742922f1.jpg	jpeg

More +